Company profile: Northeast Biolab
1.1 - Company Overview
Company description
- Provider of GLP and clinical bioanalysis services with 15+ years of experience, offering method development, validation and transfer; LC-MS bioanalysis; pharmacokinetics sample analysis and toxicokinetic safety testing; and assay platforms including ELISA, MSD, qPCR/ddPCR, Western Blot and In Cell Western for drug testing and biomarker analysis.
Products and services
- Mass Spectrometry (LC-MS): GLP-compliant LC-MS method development, validation, and analysis for therapeutics and biomarkers, generating detailed molecular information for drug testing and clinical bioanalysis workflows
- Bioanalytical Assay Development and Validation: Clinical-grade assay development and validation quantify analytes in biological matrices, ensuring reliable, reproducible data for drug development decisions
- Meso Scale Discovery (MSD) Assay: Multiplexed MSD assays support pharmacokinetics, immunogenicity, and cytokine multiplex analysis for therapeutics and biomarkers within clinical bioanalysis programs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Northeast Biolab
Safety Partners
HQ: United States
Website
- Description: Provider of environmental, health, safety, and regulatory compliance services, including permit and license management, EHS program development and implementation, industrial hygiene, animal care and use support for vivarium setup and compliance, web-based and on-site training, and lab relocation and decommissioning, including permit transfers and decontamination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Safety Partners company profile →
Southwood Research
HQ: United Kingdom
Website
- Description: Provider of pre-approval regulatory science services to the pharmaceutical and biotech industries, focusing on the science behind each product and delivering strategic clinical and regulatory insight.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Southwood Research company profile →
Financière de Tubize
HQ: Belgium
Website
- Description: Provider of investment holding focused on the biopharmaceutical industry, operating worldwide through its interest in UCB.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Financière de Tubize company profile →
Clinilabs
HQ: United States
Website
- Description: Provider of clinical drug development services specializing in CNS medications, from first-in-human to Phase 3 trials. Offers global site selection via a network in 42 countries, decentralized trials using telemedicine, electronic tools, remote assessment and wearables, corelab data services to centralize and improve data accuracy, and centralized PSG and EEG capture and analysis for clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinilabs company profile →
Jennewein Biotech
HQ: Germany
Website
- Description: Provider of industrial biotechnology solutions specializing in developing processes for the identification, characterization, and production of scarce, functional monosaccharides and oligosaccharides, with a focus on sugar molecules offering attractive health benefits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jennewein Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Northeast Biolab
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Northeast Biolab
2.2 - Growth funds investing in similar companies to Northeast Biolab
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Northeast Biolab
4.2 - Public trading comparable groups for Northeast Biolab
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →